Search images on Google Product Monograph
Active Ingredients:
- bimekizumab, 160 MG/ML
DIN: 02525275
Dosage Form(s): SOLUTION
Route(s) of Administration: SUBCUTANEOUS
Description: AUTOINJECTOR
Schedule: Prescription
Company: UCB CANADA INC
ATC:
- L04 - IMMUNOSUPPRESSANTS (ATC, WHO, Wiki)
- L04A - IMMUNOSUPPRESSANTS (ATC, WHO)
- L04AC - Interleukin inhibitors (ATC, WHO)
- L04AC21 - BIMEKIZUMAB (WHO)